首页 工具
登录
购物车
Dexmedetomidine hydrochloride

Dexmedetomidine hydrochloride

产品编号 T6466   CAS 145108-58-3
别名: Precedex, (+)-Medetomidine hydrochloride, (S)-Medetomidine hydrochloride, 盐酸右美托咪定, Dexmedetomidine HCl

Dexmedetomidine hydrochloride (Precedex) 是一种有效的、选择性的、具有口服活性的 α2 肾上腺素能受体 (α2-adrenoceptor) 激动剂,Ki=1.08 nM。它对 α1 肾上腺素受体显示出 1620 倍的选择性。它具有抗焦虑作用,可用于研究促进安定和缓解疼痛。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Dexmedetomidine hydrochloride Chemical Structure
Dexmedetomidine hydrochloride, CAS 145108-58-3
规格 价格/CNY 货期 数量
5 mg ¥ 258 现货
10 mg ¥ 369 现货
25 mg ¥ 745 现货
50 mg ¥ 1,370 现货
100 mg ¥ 2,220 现货
200 mg ¥ 3,290 现货
500 mg ¥ 5,290 现货
1 mL * 10 mM (in DMSO) ¥ 383 现货
其他形式的 Dexmedetomidine hydrochloride:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
产品目录号及名称: Dexmedetomidine hydrochloride (T6466)
点击图片重新获取验证码
选择批次  
纯度: 100.00%
纯度: 99.86%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Dexmedetomidine hydrochloride (Precedex) is an imidazole derivative that is an agonist of the adrenergic alpha-2 receptor. It is closely-related to MEDETOMIDINE, which is the racemic form of this compound.
靶点活性 α2-adrenoceptor:1.08 nM (IC50)
体内活性 Conivaptan (0.03, 0.1 and 0.3 mg/kg i.v.) dose-dependently increases urine volume and reduces urine osmolality in both myocardial infarction and sham-operated rats. Conivaptan (0.3 mg/kg i.v.) significantly reduces right ventricular systolic pressure, left ventricular end-diastolic pressure, lung/body weight and right atrial pressure in myocardial infarction rats. Conivaptan (0.3 mg/kg i.v.) significantly increases dP/dt(max)/left ventricular pressure in myocardial infarction rats. [1] Conivaptan produces an acute increase in urine volume (UV), a reduction in osmolality (UOsm) and, at the end of the investigation, cirrhotic rats receiving the V(1a)/V(2)-AVP receptor antagonist does not show hyponatremia or hypoosmolality. Conivaptan also normalizes U(Na)V without affecting creatinine clearance and arterial pressure. [2] Conivaptan (0.01 to 0.1 mg/kg i.v.) exerts a dose-dependent diuretic effect in dogs without an increase in the urinary excretion of electrolytes, inhibits the pressor effect of exogenous vasopressin in a dose-dependent manner (0.003 to 0.1 mg/kg i.v.) and, at the highest dose (0.1 mg/kg i.v.), almost completely blocks vasoconstriction caused by exogenous vasopressin. Conivaptan (0.1 mg/kg i.v.) improves cardiac function, as evidenced by significant increases in left ventricular dP/dtmax, cardiac output and stroke volume, and reduces preload and afterload, as evidenced by significant decreases in left ventricular end-diastolic pressure and total peripheral vascular resistance in dogs with congestive heart failure. [3]
激酶实验 In vitro HDAC assay:HDAC activity is analyzed by using an HDAC assay kit. This assay is based on the ability of DU-145 nuclear extract, which is rich in HDAC activity, to mediate the deacetylation of the biotinylated [3H]-acetyl histone H4 peptide that is bound to streptavidin agarose beads. The release of [3H]-acetate into the supernatant is measured to calculate the HDAC activity. Sodium butyrate (0.25-1 mM) is used as a positive control.
别名 Precedex, (+)-Medetomidine hydrochloride, (S)-Medetomidine hydrochloride, 盐酸右美托咪定, Dexmedetomidine HCl
分子量 236.74
分子式 C13H16N2·HCl
CAS No. 145108-58-3

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 23.7 mg/mL (100 mM)

H2O: 23.7 mg/mL (100 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO / H2O 1 mM 4.224 mL 21.1202 mL 42.2404 mL 105.6011 mL
5 mM 0.8448 mL 4.224 mL 8.4481 mL 21.1202 mL
10 mM 0.4224 mL 2.112 mL 4.224 mL 10.5601 mL
20 mM 0.2112 mL 1.056 mL 2.112 mL 5.2801 mL
50 mM 0.0845 mL 0.4224 mL 0.8448 mL 2.112 mL
100 mM 0.0422 mL 0.2112 mL 0.4224 mL 1.056 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Xue F, Zhang W, Chu HC.Kidney Int. 2016 May;89(5):1164. 2. Xue FS, Li RP, Liu GP, Sun C.Kidney Int. 2016 May;89(5):1163-4.
Stephanine Terazosin hydrochloride L748337 Indacaterol maleate Phentolamine mesylate Scopine hydrochloride 2-(1-Piperazinyl)pyrimidine Phenoxybenzamine hydrochloride

相关化合物库

该产品包含在如下化合物库中:
神经退行性疾病化合物库 GPCR靶点分子库 抗癌活性化合物库 EMA 上市药物库 抗癌上市药物库 抗癌药物库 药物功能重定位化合物库 膜蛋白靶向化合物库 抗癌临床化合物库 血脑屏障通透化合物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Dexmedetomidine hydrochloride 145108-58-3 GPCR/G Protein Neuroscience Adrenergic Receptor Precedex inhibit Inhibitor adrenoceptor (+)-Medetomidine (+)-Medetomidine hydrochloride Dexmedetomidine analgesia (S)-Medetomidine hydrochloride sedation Beta Receptor anxiolysis 盐酸右美托咪定 (S)-Medetomidine Dexmedetomidine Hydrochloride Dexmedetomidine HCl Medetomidine Hydrochloride inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼